Session Details

[Pj-071]Japanese Poster Session 071 Neuroimmunology (Clinical study 1)

Fri. May 23, 2025 5:15 PM - 6:35 PM JST
Fri. May 23, 2025 8:15 AM - 9:35 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chair: Yuki Hatanaka(Teikyo University School of Medicine Department of Neurology, Japan)

[Pj-071-1]Utility of antibody index related to Rheumatoid arthritis in CSF for rheumatoid meningitis

Yuki Katayama, Ryuichiro Doi, Masayoshi Matsumoto, Yansu Kim, Ayako Oniki, Hiroyuki Tomimitsu (JA toride medical center Neurology, Japan)

[Pj-071-2]Three cases of neurosarcoidosis with false-positive anti-AQP4 antibodies

Kazuki Yamada1, Sumire Nunomura2, Takashi Inoue2, Shuntaro Nakamura1, Kazuhiro Horiuchi1 (1.Department of Neurology, Hakodate Municipal Hospital, Japan, 2.Department of Neurology, Kushiro Rosai Hospital, Japan)

[Pj-071-3]Clinical characteristics of recurrent MOG antibody-associated disease in five cases

Jun Soma1, Momoko Nanbu1, Rei Ando1, Shiori Kikuchi1, Jun Sawada1, Naoki Nakagawa2, Toshiyuki Takahashi3 (1.Division of Respiratory Medicine and Neurology, Asahikawa Medical University, Japan, 2.Division of Cardiology and Nephrology, Asahikawa Medical University, Japan, 3.National Hospital Organization Yonezawa Hospital, Japan)

[Pj-071-4]Rheumatoid meningitis without active synovitis: a possible association of semaphorin 4A

Keishu Murakami1, Yoshiaki Nakayama1, Shigeru Iwata2, Seiji Emori1, Shoko Yorozu1, Takao Fujii2, Katusichi Miyamoto1 (1.Department of Neurology, Wakayama Medical University, Japan, 2.Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Japan)

[Pj-071-5]Clinical Characteristics and Treatment Course of irAE Affecting the Central Nervous System

Tomohito Ohashi, Naoya Kikutsuji, Daisuke Shimada, Katsuya Takeuchi, Hironori Shimizu, Minako Yamaoka, Yukako Nishimori, Hitoki Nanaura, Nobuyuki Eura, Takao Kiriyama, Kazuma Sugie (Nara Medical University, Department of Neurology, Japan)

[Pj-071-6]Cases of Unilateral Relapsing PCNSV

Ryo Morikawa1, Noriyoshi Nakai1, Junichiro Suzuki1, Mai Hatanaka1, Akiyoshi Tanaka1, Katsuhiko Kunitake2, Hitomi Onomura3, Yasuhiro Ito1 (1.TOYOTA Memorial Hospital, Japan, 2.Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan, 3.Youtei family clinic fujigaoka, Japan)